Diabetes: From microgravity and beyond
Wednesday 23 April 2025 at 6.30pm
Sallis Benney TheatreUniversity of 麻豆果冻传媒58-67 Grand Parade麻豆果冻传媒 and Hove麻豆果冻传媒 BN2 0JY
Over 500,000,000 people worldwide live with diabetes, with numbers increasing every year. For people with Type 1 Diabetes, daily life exists in a balance between measuring levels of glucose in the blood and injecting insulin to keep that blood glucose within a healthy target range. Can we replace the damaged insulin-producing cells in people with diabetes? Well, the answer is yes, but how this can be achieved may surprise you. The cells in our body work beautifully because they talk to each other. Utilising the extraordinary weightless environment of microgravity, we have discovered how human insulin-producing cells grow and develop in 3D. Could this be the key to producing enough human insulin-producing cells to treat all patients with diabetes? And what else can 3D microgravity cell growth teach us about human diseases? Join Professor Wendy Macfarlane to find out.
Free event. All are welcome. If you would like to attend, please register online no later than 48 hours prior to the event.
Please enable targeting cookies in order to view this video content on our website, or you can .
TEF Silver awarded for the quality of our teaching and student outcomes
We are in the top 4.3% of institutions globally, Center for World University Rankings 2025
Race Equality Charter Silver awarded for our pledge to advance representation, progression and success for minority ethnic staff and students
We are ranked 14th in Stonewall's top 100 employers for commitment to equality for LGBTQ+ staff and students
We were awarded Athena Swan Silver for advancement of gender equality, representation, progression and success for all
We are a Disability Confident employer, committed to ensuring opportunity for progression for all
Signed to the Disabled Student Commitment, an initiative to improve support for disabled students
EcoCampus Platinum accredited for our environmental sustainability, compliance and processes